Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial
February 20, 2018 | 10.4244/EIJ-D-17-00286
Showing 1-2 of 2 articles
Coronary interventions
The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study January 20, 2017 | 10.4244/EIJY15M12_02